US20070148745A1 - Process for the production of diacylglycerol - Google Patents
Process for the production of diacylglycerol Download PDFInfo
- Publication number
- US20070148745A1 US20070148745A1 US11/439,447 US43944706A US2007148745A1 US 20070148745 A1 US20070148745 A1 US 20070148745A1 US 43944706 A US43944706 A US 43944706A US 2007148745 A1 US2007148745 A1 US 2007148745A1
- Authority
- US
- United States
- Prior art keywords
- oil
- acid
- diacylglycerol
- fat
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001982 diacylglycerols Chemical class 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000000203 mixture Substances 0.000 claims abstract description 40
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000002148 esters Chemical class 0.000 claims abstract description 15
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 15
- 150000002759 monoacylglycerols Chemical class 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 230000018044 dehydration Effects 0.000 claims abstract description 8
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims description 55
- 235000019198 oils Nutrition 0.000 claims description 54
- 239000003925 fat Substances 0.000 claims description 29
- 235000019197 fats Nutrition 0.000 claims description 29
- 108090001060 Lipase Proteins 0.000 claims description 21
- 102000004882 Lipase Human genes 0.000 claims description 21
- 239000004367 Lipase Substances 0.000 claims description 20
- 235000019421 lipase Nutrition 0.000 claims description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 6
- 239000010466 nut oil Substances 0.000 claims description 6
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 5
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 claims description 4
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 238000000199 molecular distillation Methods 0.000 claims description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 claims description 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 241000589513 Burkholderia cepacia Species 0.000 claims description 3
- 241000222175 Diutina rugosa Species 0.000 claims description 3
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 3
- 241000498617 Mucor javanicus Species 0.000 claims description 3
- 241000235403 Rhizomucor miehei Species 0.000 claims description 3
- 241000303962 Rhizopus delemar Species 0.000 claims description 3
- 241000235545 Rhizopus niveus Species 0.000 claims description 3
- 240000005384 Rhizopus oryzae Species 0.000 claims description 3
- 244000299461 Theobroma cacao Species 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000001785 ferulic acid Nutrition 0.000 claims description 3
- -1 ferulic acid ester Chemical class 0.000 claims description 3
- 238000005194 fractionation Methods 0.000 claims description 3
- 238000005984 hydrogenation reaction Methods 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 239000003784 tall oil Substances 0.000 claims description 3
- 238000005809 transesterification reaction Methods 0.000 claims description 3
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 claims description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims description 2
- TWSWSIQAPQLDBP-CGRWFSSPSA-N (7e,10e,13e,16e)-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O TWSWSIQAPQLDBP-CGRWFSSPSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 claims description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 235000003320 Adansonia digitata Nutrition 0.000 claims description 2
- 244000056971 Adansonia gregorii Species 0.000 claims description 2
- 235000003319 Adansonia gregorii Nutrition 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000226021 Anacardium occidentale Species 0.000 claims description 2
- 241001673904 Argania Species 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims description 2
- 235000021357 Behenic acid Nutrition 0.000 claims description 2
- 235000012284 Bertholletia excelsa Nutrition 0.000 claims description 2
- 244000205479 Bertholletia excelsa Species 0.000 claims description 2
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims description 2
- 235000021292 Docosatetraenoic acid Nutrition 0.000 claims description 2
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 claims description 2
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims description 2
- 235000003239 Guizotia abyssinica Nutrition 0.000 claims description 2
- 240000002795 Guizotia abyssinica Species 0.000 claims description 2
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 2
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 241000235395 Mucor Species 0.000 claims description 2
- 244000183331 Nephelium lappaceum Species 0.000 claims description 2
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 239000005643 Pelargonic acid Substances 0.000 claims description 2
- 235000004347 Perilla Nutrition 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims description 2
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 claims description 2
- 235000019497 Pistachio oil Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 241000589516 Pseudomonas Species 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 241000235527 Rhizopus Species 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 2
- 235000019498 Walnut oil Nutrition 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 claims description 2
- 238000005377 adsorption chromatography Methods 0.000 claims description 2
- 229940108929 alfalfa oil Drugs 0.000 claims description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 2
- 235000020224 almond Nutrition 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 239000010480 babassu oil Substances 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- 229940116226 behenic acid Drugs 0.000 claims description 2
- 239000010473 blackcurrant seed oil Substances 0.000 claims description 2
- 235000021324 borage oil Nutrition 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 235000019519 canola oil Nutrition 0.000 claims description 2
- 239000000828 canola oil Substances 0.000 claims description 2
- 235000013709 carrot oil Nutrition 0.000 claims description 2
- 235000020226 cashew nut Nutrition 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 2
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 2
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 claims description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 2
- 229960002733 gamolenic acid Drugs 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- 239000010468 hazelnut oil Substances 0.000 claims description 2
- 239000010460 hemp oil Substances 0.000 claims description 2
- 239000010507 melon oil Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 239000003346 palm kernel oil Substances 0.000 claims description 2
- 235000019865 palm kernel oil Nutrition 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000010471 pistachio oil Substances 0.000 claims description 2
- 229940082415 pistachio oil Drugs 0.000 claims description 2
- 239000010491 poppyseed oil Substances 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 2
- 239000008171 pumpkin seed oil Substances 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 235000007861 rambutan Nutrition 0.000 claims description 2
- 239000008165 rice bran oil Substances 0.000 claims description 2
- 239000010667 rosehip oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 239000003760 tallow Substances 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- AQWHMKSIVLSRNY-UHFFFAOYSA-N trans-Octadec-5-ensaeure Natural products CCCCCCCCCCCCC=CCCCC(O)=O AQWHMKSIVLSRNY-UHFFFAOYSA-N 0.000 claims description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 2
- 229940005605 valeric acid Drugs 0.000 claims description 2
- 239000008170 walnut oil Substances 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims 4
- 239000008162 cooking oil Substances 0.000 claims 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims 2
- 229940114124 ferulic acid Drugs 0.000 claims 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 16
- 229940068065 phytosterols Drugs 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 239000012530 fluid Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 108010048733 Lipozyme Proteins 0.000 description 2
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000021183 entrée Nutrition 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000012177 snack cakes Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6458—Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6418—Fatty acids by hydrolysis of fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- the present invention relates to the production of diacylglycerols. More particularly, the present invention relates to a process for producing a high-purity diacylglycerol at a high yield in a short period of time.
- Diacylglycerols are widely used in a variety of applications such as additives for improving plasticity of oils and fats, as well as edible oils in the food industry, and as a base material for the production of cosmetics and drugs.
- the preparation of such diacylglycerols involves an esterification reaction of glycerol with its corresponding fatty acid, an alcohol interchange reaction of glycerol with oil or fat, or the like, with the use of an alkali catalyst, or an enzyme such as a lipase, or the like.
- an enzyme catalyst is preferable from the viewpoints of the yield and purity of the diacylglycerols synthesised and energy savings.
- Japanese Patent Application No. 71495/1989 describes a lipase-catalysed reaction process that includes the reaction of a fatty acid or the like with glycerol in the presence of a 1,3-position selective lipase while removing water formed by the reaction outside the system to obtain a diacylglycerol at high yield and purity.
- the drawback of this process is that it is not able to investigate production conditions at an industrial level.
- Japanese Patent Application No. 330289/1992 describes a process in which glycerol is added in an equimolar amount or more to a fatty acid to react. The reaction is stopped when the concentration of a diacylglycerol has been enhanced, insoluble glycerol is separated, and the reaction is further conducted while dehydrating, thereby synthesising diacylglycerol at a high esterification reaction rate by improving dehydration efficiency.
- This process involves technical difficulties such as necessity of stopping the reaction at the time the concentration of the diglyceride reaches a peak.
- Japanese Patent Application No. 234391/1998 describes a process in which a mixture of a fatty acid or the like and glycerol or the like is reacted in a flow tube type reactor filled with a lipase while controlling the superficial velocity of the mixture in the reactor to at least 0.05 cm/s.
- This technique is easy to operate and can improve the reaction rate to some extent, but is insufficient in the purity of the resulting diglyceride and the industrial scale-up technique.
- U.S. Pat. No. 6,361,980 describes a process for preparing diacylglycerol, which comprises of an enzyme-packed tower that includes an immobilised lipase preparation, carrying out an esterification reaction between: (1) an acyl group donor selected from the group consisting of a fatty acid, a lower alcohol ester thereof, and a mixture thereof; and (2) an acyl group acceptor selected from the group consisting of glycerol, a monoacylglycerol, and a mixture thereof; to obtain a reaction fluid from said enzyme-packed tower; reducing the water content or lower alcohol content in said reaction fluid; and subsequent to said reducing, recirculating the reaction fluid to said enzyme-packed tower, wherein a residence time of said reaction fluid in said enzyme-packed tower is 120 seconds or less; to obtain a diacylglycerol, wherein said reducing comprises dehydrating or de-alcoholising said reaction fluid is by feeding said reaction fluid though a spray nozzle, in a dehydration process.
- a process for the production of a high-purity diacylglycerol at a high yield in a short period of time comprising:
- a high-purity diacylglycerol can be produced at a high-yield in a short period of time.
- an oil or fat composition comprising of diacylglycerol produced herein and phytosteryl esters and/or ferulic acid esters.
- the present invention provides a process for producing a high-purity diacylglycerol at a high yield and a short period of time.
- the process for producing diacylglycerol in accordance with the present invention is comprised of the following steps:
- step (i) involves controlled hydrolysis reaction which is conducted in the presence of water.
- the amount of water in the reaction fluid is from 20 to 180 parts by weight per 100 parts by weight of the triacylglycerol.
- the hydrolysis reaction in the present invention is controlled so that the amount of free fatty acids resulting from the controlled hydrolysis ranges from 5% to 50% by weight, preferably from 25% to 35% by weight.
- the enzyme used in the present invention is an enzyme having a hydrolytic activity, such as a lipase, and preferably immobilised onto a suitable enzyme carrier, such as an ion exchange resin.
- a hydrolytic activity such as a lipase
- the said lipase can possess non-position specific or 1,3-position specific.
- lipases that can be used in the present invention can be derived from microorganisms of the genera Rhizopus, Aspergillus, Mucor, Candida, Pseudomonas etc.
- the immobilised lipase preparation is obtained by immobilising a lipase according to a known method for immobilising an enzyme.
- Examples of preferred equipment for the controlled hydrolysis reaction used in the enzymatic method of the present invention include an agitation tank, a fixed bed, a fluidised tank, and combinations thereof.
- the controlled hydrolysis reaction can be conducted in a batchwise, continuous, or semi-continuous manner.
- the controlled hydrolysis of the present invention is conducted by way of enzymatic hydrolysis, the controlled hydrolysis is conducted at a temperature within the operational temperature of the said lipase, preferably from 20° C. to 90° C.
- dehydration of the reaction fluid is conducted using conventional water removal methods such as centrifugation, condensation, distillation, evaporation or absorption.
- the triacylglycerol used in the present invention include conventional vegetable and animal fats and oils or processed fats and oils comprising of C 2 -C 24 saturated or unsaturated fatty acids or mixtures thereof, such as acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecanoic acid, lauric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, zoomaric acid, stearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, ⁇ -linolenic acid, ⁇ -linolenic acid, stearidonic acid, arachidic acid, arachidonic acid, gadoleic acid, arachic acid, dihomo- ⁇ -linolenic acid, eicosapentaenoic acid, behenic acid,
- Examples of vegetable and animal oils or fats which may be used in the present invention are canola oil, coconut oil, corn oil, cottonseed oil, palm oil, palm kernel oil, peanut oil, rapeseed oil, safflower oil, soybean oil, sunflower oil, olive oil, rice bran oil, corn bran oil, borage oil, evening primrose oil, flaxseed oil, grape seed oil, linseed oil, argania oil alfalfa oil, almond seed oil, apricot kernel oil, avocado oil, babassu oil, baobab oil, blackcurrant seed oil, brazil nut oil, cocoa seed oil, camellia oil, carrot oil, cashew nut oil, hazelnut oil, hemp seed oil, kiwi seed oil, macadamia nut oil, mango seed oil, melon seed oil, niger seed oil, peach kernel oil, perilla oil, pistachio oil, poppy seed oil, pumpkin seed oil, rambutan seed oil, rosehip oil, sesame oil,
- the separation methods for use in separating monoacylglycerols, free fatty acids and residual triacylglycerols from diacylglycerols may be, for example deodorisation, steam distillation, molecular distillation, adsorption chromatography, and any combination of thereof.
- the separation methods may be conducted batchwise, continuous, and semi-continuous.
- diacylglycerol purity which in the present invention is defined as a ratio of diacylglycerol weight % to (diacylglycerol weight %+triacylglycerol weight %) ⁇ 100 is used to measure the diacylglycerol concentration of the refined oil or fat composition used in the present invention.
- a composition comprising of diacylglycerol ranging from 10% to 96% can be obtained.
- the resulting product may contain a small proportion of unhydrolysed triacylglycerol.
- An oil or fat composition comprising of diacylglycerol produced from the process described herein and phytosteryl esters of fatty acids and/or ferulic acid esters can be obtained.
- the oil or fat composition obtained from the present invention can assist in lowering and preventing the risks of cardiovascular diseases and its underlying conditions such as hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, thrombosis, as well as other diseases such as Type II diabetes, dementia, cancer, aging and those diseases which include oxidative damage as part of the disease pathology.
- Phytosteryl esters and/or ferulic acid esters are melted down, at temperatures ranging from 120° C.
- the amount of phytosteryl esters and/or ferulic acid esters used in the present invention is preferably from 0.5% to 25% by weight of diacylglycerol.
- Phytosterols or plant sterols, are natural constituents of the human diet and are commonly found as minor constituents of vegetable oils. They are structurally related to cholesterol, but differ in their side-chain configuration. Phytosterols are generally extracted from by-products of either pulp and paper industry (wood-derived; “tall oil soap”) or vegetable oil industry (vegetable-derived) using organic solvents (hexanes and acetone). A purified phytosterol mixture is white in colour (similar to cholesterol) with extremely low solubility. Similar to their appearance, cholesterol and phytosterols have similar chemical structures. There are a wide variety of phytosterols found in nature, but the most common ones are ⁇ -sitosterol, campesterol and stigmasterol.
- phytosterols are naturally found in various parts of plants including oil-bearing seeds, nuts and fruits. Vegetable oils derived from these parts contain phytosterols in about 0.1 to 1.0 weight % of oil. In addition to their daily consumption, the use of phytosterols as cholesterol-lowering agents has been recently reconsidered. This resulted in marketing phytosterol-enriched food products (“functional foods”) in North America and Europe. These products are intended to be used by a wide range of subjects including those with dyslipidemia. Although their pharmacological properties have not been fully explored, phytosterols have been effective in reducing plasma cholesterol levels without causing any serious side-effects.
- Phytosterols are also used in the treatment of cardiovascular diseases and its underlying conditions such as hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, thrombosis, as well as other diseases such as Type II diabetes, dementia, cancer, aging and those diseases which include oxidative damage as part of the disease pathology.
- phytosteryl esters of fatty acids may result in a better outcome as compared to free phytosterols.
- Undissolved phytosterols have poor solubility in the micellar phase in the digestive tract and therefore are not capable of efficiently blocking cholesterol absorption.
- an oil or fat such as edible oil or fat.
- phytosterols have a relatively lower solubility in oil or fat compared to their esters. Since phytosteryl esters have a relatively higher solubility in oil or fat than phytosterols, a higher concentration of these esters can be dissolved in oil or fat than phytosterols. Therefore, the physiological effects of phytosteryl esters can be made more effective and efficient than that of phytosterols.
- Ferulic acid esters are known anti-oxidants which are generally more soluble in lipids. Ferulic acid esters comprise of oryzanols, more preferably ⁇ -oryzanol, which can be found in rice and corn bran oils. Ferulic acids esters are known to be reducing the risks of cancer, lowering cholesterol level, and possess muscle-building property.
- the oil or fat composition of the present invention can be used similarly to ordinary edible oils and fats, and can be applied to fat-processed foods, such as oil-in-water type fat-processed foods, drinks, desserts, ice-creams, dressings, toppings, mayonnaises, and sauces; water-in-oil type fat-processed foods such as margarines and spreads; processed fat foods such as peanut butters, frying and baking shortenings; processed foods such as potato chips, snack cakes, cakes, cookies, pies, pastries, breads, and chocolates; and other foods including bakery mixes, processed meat products, frozen entrees, and frozen foods.
- fat-processed foods such as oil-in-water type fat-processed foods, drinks, desserts, ice-creams, dressings, toppings, mayonnaises, and sauces
- water-in-oil type fat-processed foods such as margarines and spreads
- processed fat foods such as peanut butters, frying and baking shortenings
- oil or fat composition used in the present invention can be applied as a hypocholesteremic preparation in the form of a capsule, sugar-coated tablet, molded granules, candy, or drop.
- Example 1 Example 2
- Example 2 Free Fatty acids (%) 0.03 0.04 25.21 22.74 Monoacylglycerols (%) 0.93 1.17 21.98 23.22 Diacylglycerols (%) 2.64 3.36 41.56 43.68 Triacylglycerols (%) 96.40 95.43 11.25 10.36
- ⁇ -sitosteryl ester Prior to the addition of ⁇ -sitosteryl ester, approximately 200 g of the purified diacylglycerol oil obtained from Example 1 was maintained at approximately 150° C. 16 grams of crystallised ⁇ -sitosteryl ester was added into the heated diacylglycerol oil and mixed for several minutes, while the temperature of the oil was allowed to cool slowly to room temperature.
- ⁇ -oryzanol Prior to the addition of ⁇ -oryzanol, approximately 200 g of the purified diacylglycerol oil obtained from Example 2 was maintained at approximately 150° C. 10 grams of crystallised ⁇ -oryzanol was added into the heated diacylglycerol oil and mixed for several minutes, while the temperature of the oil was allowed to cool slowly to room temperature.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
The present invention provides a process for producing a diacylglycerol, which comprises, reacting triacylglycerol with water and an enzyme to obtain a mixture comprising of diacylglycerol, monoacylglycerol and free fatty acid; removing water content in the mixture by way of dehydration; and separating monoacylglycerol, free fatty acid and residual triacylglycerol by at least one separation method to obtain a high-purity diacylglycerol. An oil or fat composition comprising of diacylglycerol obtained from the said process and phytosteryl esters and/or ferulic acid esters in an amount of from 0.5% to 25% by weight of diacylglycerol is also provided.
Description
- The present invention relates to the production of diacylglycerols. More particularly, the present invention relates to a process for producing a high-purity diacylglycerol at a high yield in a short period of time.
- Diacylglycerols are widely used in a variety of applications such as additives for improving plasticity of oils and fats, as well as edible oils in the food industry, and as a base material for the production of cosmetics and drugs. Generally, the preparation of such diacylglycerols involves an esterification reaction of glycerol with its corresponding fatty acid, an alcohol interchange reaction of glycerol with oil or fat, or the like, with the use of an alkali catalyst, or an enzyme such as a lipase, or the like. However, the use of an enzyme catalyst is preferable from the viewpoints of the yield and purity of the diacylglycerols synthesised and energy savings.
- Japanese Patent Application No. 71495/1989 describes a lipase-catalysed reaction process that includes the reaction of a fatty acid or the like with glycerol in the presence of a 1,3-position selective lipase while removing water formed by the reaction outside the system to obtain a diacylglycerol at high yield and purity. The drawback of this process is that it is not able to investigate production conditions at an industrial level.
- Japanese Patent Application No. 330289/1992 describes a process in which glycerol is added in an equimolar amount or more to a fatty acid to react. The reaction is stopped when the concentration of a diacylglycerol has been enhanced, insoluble glycerol is separated, and the reaction is further conducted while dehydrating, thereby synthesising diacylglycerol at a high esterification reaction rate by improving dehydration efficiency. This process involves technical difficulties such as necessity of stopping the reaction at the time the concentration of the diglyceride reaches a peak.
- Japanese Patent Application No. 234391/1998 describes a process in which a mixture of a fatty acid or the like and glycerol or the like is reacted in a flow tube type reactor filled with a lipase while controlling the superficial velocity of the mixture in the reactor to at least 0.05 cm/s. This technique is easy to operate and can improve the reaction rate to some extent, but is insufficient in the purity of the resulting diglyceride and the industrial scale-up technique.
- U.S. Pat. No. 6,361,980 describes a process for preparing diacylglycerol, which comprises of an enzyme-packed tower that includes an immobilised lipase preparation, carrying out an esterification reaction between: (1) an acyl group donor selected from the group consisting of a fatty acid, a lower alcohol ester thereof, and a mixture thereof; and (2) an acyl group acceptor selected from the group consisting of glycerol, a monoacylglycerol, and a mixture thereof; to obtain a reaction fluid from said enzyme-packed tower; reducing the water content or lower alcohol content in said reaction fluid; and subsequent to said reducing, recirculating the reaction fluid to said enzyme-packed tower, wherein a residence time of said reaction fluid in said enzyme-packed tower is 120 seconds or less; to obtain a diacylglycerol, wherein said reducing comprises dehydrating or de-alcoholising said reaction fluid is by feeding said reaction fluid though a spray nozzle, in a dehydration process. However, this process is costly as it requires the use of expensive purified fatty acids as raw material.
- In view of the above, it would be advantageous to provide a process for producing a high-purity diacylglycerol at a high yield in a short period of time at an industrial level.
- According to the present invention, there is provided a process for the production of a high-purity diacylglycerol at a high yield in a short period of time, said process comprising:
-
- reacting triacylglycerol with water and an enzyme to obtain a mixture of diacylglycerol, monoacylglycerol and free fatty acid;
- removing water content in the mixture by way of dehydration; and
- separating the said monoacylglycerol, free fatty acid and residual triacylglycerol by one or more separation methods to obtain a high-purity diacylglycerol.
- According to the present invention, a high-purity diacylglycerol can be produced at a high-yield in a short period of time.
- In another aspect of the present invention, there is provided an oil or fat composition comprising of diacylglycerol produced herein and phytosteryl esters and/or ferulic acid esters.
- Various other objects, features and attendant advantages of the present invention will be more fully appreciated as the same becomes better understood from the following detailed description of the preferred embodiments of the invention.
- The present invention provides a process for producing a high-purity diacylglycerol at a high yield and a short period of time. Where the features and details of the invention, either as steps of the invention or as combination of parts of the invention will now be described in greater detail. It will be understood to a person skilled in the art that the particular embodiments of the invention are shown by way of example illustration and not as limitations of the. invention. While these examples are presented to show one skilled in the art how to operate within the scope of this invention, they are not to serve as a limitation on the scope of the invention where such scope is only defined in the claims.
- The process for producing diacylglycerol in accordance with the present invention is comprised of the following steps:
-
- (i) reacting triacylglycerol with water and an enzyme to obtain a mixture comprising of diacylglycerol, monoacylglycerol and free fatty acid;
- (ii) removing water content in the mixture by a dehydration method; and
- (iii) separating the said monoacylglycerol, free fatty acid and residual triacylglycerol by one or more separation method(s) to obtain a high-purity diacylglycerol.
- According to the present invention, step (i) involves controlled hydrolysis reaction which is conducted in the presence of water. From the viewpoint of enhancing the purity and production rate of the diacylglycerol, it is preferred that the amount of water in the reaction fluid is from 20 to 180 parts by weight per 100 parts by weight of the triacylglycerol.
- It is preferred that the hydrolysis reaction in the present invention is controlled so that the amount of free fatty acids resulting from the controlled hydrolysis ranges from 5% to 50% by weight, preferably from 25% to 35% by weight.
- The enzyme used in the present invention is an enzyme having a hydrolytic activity, such as a lipase, and preferably immobilised onto a suitable enzyme carrier, such as an ion exchange resin. The said lipase can possess non-position specific or 1,3-position specific. Examples of lipases that can be used in the present invention can be derived from microorganisms of the genera Rhizopus, Aspergillus, Mucor, Candida, Pseudomonas etc. For example, Rhizopus delemar, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Mucor javanicus, Mucor miehei, Candida rugosa, Candida antarctica, Pseudomonas cepacia and the like. The immobilised lipase preparation is obtained by immobilising a lipase according to a known method for immobilising an enzyme.
- Examples of preferred equipment for the controlled hydrolysis reaction used in the enzymatic method of the present invention include an agitation tank, a fixed bed, a fluidised tank, and combinations thereof. The controlled hydrolysis reaction can be conducted in a batchwise, continuous, or semi-continuous manner.
- Since the controlled hydrolysis of the present invention is conducted by way of enzymatic hydrolysis, the controlled hydrolysis is conducted at a temperature within the operational temperature of the said lipase, preferably from 20° C. to 90° C.
- It is preferred that dehydration of the reaction fluid is conducted using conventional water removal methods such as centrifugation, condensation, distillation, evaporation or absorption.
- The triacylglycerol used in the present invention include conventional vegetable and animal fats and oils or processed fats and oils comprising of C2-C24 saturated or unsaturated fatty acids or mixtures thereof, such as acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecanoic acid, lauric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, zoomaric acid, stearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, stearidonic acid, arachidic acid, arachidonic acid, gadoleic acid, arachic acid, dihomo-γ-linolenic acid, eicosapentaenoic acid, behenic acid, erucic acid, adrenic acid, docosapentaenoic acid, docosahexaenoic acid, nervonic acid, or an isomeric form thereof. Examples of vegetable and animal oils or fats which may be used in the present invention are canola oil, coconut oil, corn oil, cottonseed oil, palm oil, palm kernel oil, peanut oil, rapeseed oil, safflower oil, soybean oil, sunflower oil, olive oil, rice bran oil, corn bran oil, borage oil, evening primrose oil, flaxseed oil, grape seed oil, linseed oil, argania oil alfalfa oil, almond seed oil, apricot kernel oil, avocado oil, babassu oil, baobab oil, blackcurrant seed oil, brazil nut oil, cocoa seed oil, camellia oil, carrot oil, cashew nut oil, hazelnut oil, hemp seed oil, kiwi seed oil, macadamia nut oil, mango seed oil, melon seed oil, niger seed oil, peach kernel oil, perilla oil, pistachio oil, poppy seed oil, pumpkin seed oil, rambutan seed oil, rosehip oil, sesame oil, shea seed oil, tall oil, walnut oil and wheat germ oil, beef tallow, lard, fish oil; oils or fats obtained from the process of hardening, hydrogenation, transesterification, or randomisation, fractionation, distillation; and mixtures thereof.
- The separation methods for use in separating monoacylglycerols, free fatty acids and residual triacylglycerols from diacylglycerols may be, for example deodorisation, steam distillation, molecular distillation, adsorption chromatography, and any combination of thereof. The separation methods may be conducted batchwise, continuous, and semi-continuous.
- It is preferred that the process of the present invention is continuously performed until a final product containing diacylglycerol purity ranging from 10% to 96% is obtained. Diacylglycerol purity, which in the present invention is defined as a ratio of diacylglycerol weight % to (diacylglycerol weight %+triacylglycerol weight %)×100 is used to measure the diacylglycerol concentration of the refined oil or fat composition used in the present invention. According to the present invention, a composition comprising of diacylglycerol ranging from 10% to 96% can be obtained. The resulting product may contain a small proportion of unhydrolysed triacylglycerol.
- An oil or fat composition comprising of diacylglycerol produced from the process described herein and phytosteryl esters of fatty acids and/or ferulic acid esters can be obtained. The oil or fat composition obtained from the present invention can assist in lowering and preventing the risks of cardiovascular diseases and its underlying conditions such as hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, thrombosis, as well as other diseases such as Type II diabetes, dementia, cancer, aging and those diseases which include oxidative damage as part of the disease pathology. Phytosteryl esters and/or ferulic acid esters are melted down, at temperatures ranging from 120° C. to 150° C., into a molten form before being mixed with the diacylglycerol oil produced from the present invention. The mixture is homogenised and allowed to cool at room temperature. The amount of phytosteryl esters and/or ferulic acid esters used in the present invention is preferably from 0.5% to 25% by weight of diacylglycerol.
- Phytosterols, or plant sterols, are natural constituents of the human diet and are commonly found as minor constituents of vegetable oils. They are structurally related to cholesterol, but differ in their side-chain configuration. Phytosterols are generally extracted from by-products of either pulp and paper industry (wood-derived; “tall oil soap”) or vegetable oil industry (vegetable-derived) using organic solvents (hexanes and acetone). A purified phytosterol mixture is white in colour (similar to cholesterol) with extremely low solubility. Similar to their appearance, cholesterol and phytosterols have similar chemical structures. There are a wide variety of phytosterols found in nature, but the most common ones are β-sitosterol, campesterol and stigmasterol. Phytosterols are naturally found in various parts of plants including oil-bearing seeds, nuts and fruits. Vegetable oils derived from these parts contain phytosterols in about 0.1 to 1.0 weight % of oil. In addition to their daily consumption, the use of phytosterols as cholesterol-lowering agents has been recently reconsidered. This resulted in marketing phytosterol-enriched food products (“functional foods”) in North America and Europe. These products are intended to be used by a wide range of subjects including those with dyslipidemia. Although their pharmacological properties have not been fully explored, phytosterols have been effective in reducing plasma cholesterol levels without causing any serious side-effects. Phytosterols are also used in the treatment of cardiovascular diseases and its underlying conditions such as hypercholesterolemia, hyperlipidemia, atherosclerosis, hypertension, thrombosis, as well as other diseases such as Type II diabetes, dementia, cancer, aging and those diseases which include oxidative damage as part of the disease pathology.
- Recently, studies have suggested that phytosteryl esters of fatty acids may result in a better outcome as compared to free phytosterols. Undissolved phytosterols have poor solubility in the micellar phase in the digestive tract and therefore are not capable of efficiently blocking cholesterol absorption. To increase the blood cholesterol lowering effect of phytosterols or its esters, it has to be homogenously dissolved in an oil or fat, such as edible oil or fat. However, phytosterols have a relatively lower solubility in oil or fat compared to their esters. Since phytosteryl esters have a relatively higher solubility in oil or fat than phytosterols, a higher concentration of these esters can be dissolved in oil or fat than phytosterols. Therefore, the physiological effects of phytosteryl esters can be made more effective and efficient than that of phytosterols.
- Ferulic acid esters are known anti-oxidants which are generally more soluble in lipids. Ferulic acid esters comprise of oryzanols, more preferably γ-oryzanol, which can be found in rice and corn bran oils. Ferulic acids esters are known to be reducing the risks of cancer, lowering cholesterol level, and possess muscle-building property.
- The oil or fat composition of the present invention can be used similarly to ordinary edible oils and fats, and can be applied to fat-processed foods, such as oil-in-water type fat-processed foods, drinks, desserts, ice-creams, dressings, toppings, mayonnaises, and sauces; water-in-oil type fat-processed foods such as margarines and spreads; processed fat foods such as peanut butters, frying and baking shortenings; processed foods such as potato chips, snack cakes, cakes, cookies, pies, pastries, breads, and chocolates; and other foods including bakery mixes, processed meat products, frozen entrees, and frozen foods.
- It is also preferred that the oil or fat composition used in the present invention can be applied as a hypocholesteremic preparation in the form of a capsule, sugar-coated tablet, molded granules, candy, or drop.
- The following examples illustrate the invention.
- In a 5 L flask, 1000 g of refined palm olein was mixed with 1000 g of distilled water and 100 g of “Lipozyme RM IM”, an immobilised 1,3-position selective lipase obtained from Rhizomucor miehei lipase. The mixture was reacted for 10 hours under stirring at 60° C. Thereafter, the lipase preparation was removed from the reaction product. Samples of the product were removed, and the amount of free fatty acids and partial acylglycerols was determined by gas chromatography. The results are shown in Table 1.
- In a 5 L flask, 1000 g of refined soybean oil was mixed with 1000 g of distilled water and 100 g of “Lipozyme RM IM”, an immobilised 1,3-position selective lipase obtained from Rhizomucor miehei lipase. The mixture was reacted for 10 hours under stirring at 60° C. Thereafter, the lipase preparation was removed from the reaction product. Samples of the product were removed, and the amount of free fatty acids and partial acylglycerols was determined by gas chromatography. The results are shown in Table 1.
TABLE 1 Reactants before Reaction hydrolysis Hydrolysis product components Example 1 Example 2 Example 1 Example 2 Free Fatty acids (%) 0.03 0.04 25.21 22.74 Monoacylglycerols (%) 0.93 1.17 21.98 23.22 Diacylglycerols (%) 2.64 3.36 41.56 43.68 Triacylglycerols (%) 96.40 95.43 11.25 10.36 - The hydrolysis products from Examples 1 and 2 were centrifuged at 5000 rpm for 10 minutes to separate the oil phase from the aqueous phase. The oil phase was subjected to molecular distillation at a temperature of 160° C. and at a pressure of 0.001 mbar to obtain the free fatty acids and monoacylglycerols as distillate 1 and diacylglycerol and triacylglycerol as residue 1. A further molecular distillation step at 210° C. and 0.001 mbar was performed to obtain the diacylglycerol as distillate 2 and triacylglycerol as residue 2. The results are shown in Table 2.
TABLE 2 Diacylglycerol purity (%) Hydrolysis product Before purification After purification Example 1 41.56 88.70 Example 2 43.68 90.83 - Prior to the addition of β-sitosteryl ester, approximately 200 g of the purified diacylglycerol oil obtained from Example 1 was maintained at approximately 150° C. 16 grams of crystallised β-sitosteryl ester was added into the heated diacylglycerol oil and mixed for several minutes, while the temperature of the oil was allowed to cool slowly to room temperature.
- Prior to the addition of γ-oryzanol, approximately 200 g of the purified diacylglycerol oil obtained from Example 2 was maintained at approximately 150° C. 10 grams of crystallised γ-oryzanol was added into the heated diacylglycerol oil and mixed for several minutes, while the temperature of the oil was allowed to cool slowly to room temperature.
Claims (17)
1. A process for the production of diacylglycerol comprising the steps of:
(i) reacting triacylglycerol with water and an enzyme at a temperature ranging from 20° C. to 90° C. to obtain a mixture of diacylglycerol, monoacylglycerol and free fatty acid;
(ii) removing water content in the mixture of step (i) by way of dehydration; and
(iii) separating said monoacylglycerol, free fatty acid and residual triacylglycerol by at least one separation method to obtain a high-purity diacylglycerol;
wherein the amount of water in the reaction mixture of step (i) is from 20 to 180 parts by weight per 100 parts by weight of the triacylglycerol and step (i) is conducted until between 5% and 50% of free fatty acids is obtained, thus producing diacylglycerol of up to 96% purity at a high yield in a short period of time.
2. A process according to claim 1 , wherein said enzyme in step (i) is a lipase.
3. A process according to claim 2 , wherein said lipase is an immobilised lipase.
4. A process according to claim 3 , wherein said immobilised lipase enzyme preparation comprises an immobilised non-position and/or 1,3-position selective lipase which is selected from the group consisting of lipases derived from microorganisms of the genera Rhizopus, Aspergillus, Mucor, Candida and Pseudomonas, lipases derived from Rhizopus delemar, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Mucor javanicus, Mucor miehei, Candida rugosa, Candida antarctica, Pseudomonas cepacia Rhizopus delemar, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Mucor javanicus, Mucor miehei, Candida rugosa, Candida antarctica, Pseudomonas cepacia.
5. A process according to claim 1 , wherein said triacylglycerol used in step (i) is selected from the group consisting of vegetable and animal fats, or oils, and mixtures thereof.
6. A process according to claim 5 , wherein said fat or oil is selected from the group consisting of canola oil, coconut oil, corn oil, cottonseed oil, palm oil, palm kernel oil, peanut oil, rapeseed oil, safflower oil, soybean oil, sunflower oil, olive oil, rice bran oil, corn bran oil, borage oil, evening primrose oil, flaxseed oil, grape seed oil, linseed oil, argania oil alfalfa oil, almond seed oil, apricot kernel oil, avocado oil, babassu oil, baobab oil, blackcurrant seed oil, brazil nut oil, cocoa seed oil, camellia oil, carrot oil, cashew nut oil, hazelnut oil, hemp seed oil, kiwi seed oil, macadamia nut oil, mango seed oil, melon seed oil, niger seed oil, peach kernel oil, perilla oil, pistachio oil, poppy seed oil, pumpkin seed oil, rambutan seed oil, rosehip oil, sesame oil, shea seed oil, tall oil, walnut oil and wheat germ oil, beef tallow, lard, fish oil; oils or fats obtained from the process of hardening, hydrogenation, trans-esterification, or randomisation, fractionation, distillation; and mixtures thereof.
7. A process according to claim 1 , wherein said triacylglycerol comprises of saturated or unsaturated fatty acids having 2 to 24 carbon atoms, such as acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecanoic acid, lauric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, zoomaric acid, stearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, stearidonic acid, arachidic acid, arachidonic acid, gadoleic acid, arachic acid, dihomo-ã-linolenic acid, eicosapentaenoic acid, behenic acid, erucic acid, adrenic acid, docosapentaenoic acid, docosahexaenoic acid, nervonic acid, or an isomeric form thereof, or fatty acids obtained by processing of oils or fats, hardening, hydrogenation, transesterification, or randomisation, fractionation, distillation; and mixtures thereof.
8. A process according to claim 1 , wherein said dehydration method may be, for example centrifugation, condensation, distillation, evaporation or absorption.
9. A process according to claim 1 , wherein said separation method may be, for example steam distillation, molecular distillation or adsorption chromatography.
10. An oil or fat composition comprising of diacylglycerol in an amount of up to 96% by weight as defined in the process as claimed in claim 1 .
11. An oil or fat composition according to claim 10 , wherein said composition further includes at least one phytosteryl ester in an amount ranging from 0.5% to 25% by weight of diacylglycerol.
12. An oil or fat composition as claimed in claim 11 , wherein said composition further includes at least one ferulic acid ester in an amount ranging from 0.5% to 25% by weight of diacylglycerol.
13. An oil or fat composition as claimed in claim 10 , wherein said composition further includes at least one ferulic acid ester in an amount ranging from 0.5% to 25% by weight of diacylglycerol.
14. An oil or fat-processed food product, a beverage product and a cooking oil product comprising of an oil or fat composition as defined in claim 10 .
15. An oil or fat-processed food product, a beverage product and a cooking oil product comprising of an oil or fat composition as defined in claim 11 .
16. An oil or fat-processed food product, a beverage product and a cooking oil product comprising of an oil or fat composition as defined in claim 12 .
17. An oil or fat-processed food product, a beverage product and a cooking oil product comprising of an oil or fat composition as defined in claim 13.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20056218 | 2005-12-28 | ||
MYPI20056218A MY142033A (en) | 2005-12-28 | 2005-12-28 | Process for the production of diacylglycerol |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070148745A1 true US20070148745A1 (en) | 2007-06-28 |
Family
ID=43857578
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/439,447 Abandoned US20070148745A1 (en) | 2005-12-28 | 2006-05-24 | Process for the production of diacylglycerol |
US12/159,430 Expired - Fee Related US7943335B2 (en) | 2005-02-28 | 2006-12-28 | Process for the production of diacylglycerol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/159,430 Expired - Fee Related US7943335B2 (en) | 2005-02-28 | 2006-12-28 | Process for the production of diacylglycerol |
Country Status (9)
Country | Link |
---|---|
US (2) | US20070148745A1 (en) |
EP (2) | EP1803819B1 (en) |
JP (2) | JP2007175049A (en) |
AT (2) | ATE443773T1 (en) |
DE (2) | DE602006009367D1 (en) |
ES (2) | ES2333461T3 (en) |
HK (1) | HK1124366A1 (en) |
MY (1) | MY142033A (en) |
WO (1) | WO2007075079A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011075802A1 (en) | 2009-12-24 | 2011-06-30 | Companhia Refinadora Da Amazônia | Production of diacylglycerols by lipase - catalyzed hydrolysis of palm oil |
CN107326050A (en) * | 2017-07-13 | 2017-11-07 | 暨南大学 | A kind of purification process of middle chain and middle long-chain mixing diglyceride |
WO2019234057A1 (en) | 2018-06-05 | 2019-12-12 | Dsm Ip Assets B.V. | Process for the production of diglycerides |
CN111378700A (en) * | 2020-02-24 | 2020-07-07 | 广东聚石化学股份有限公司 | Preparation method of camellia oil fatty acid ester |
CN111961527A (en) * | 2020-09-03 | 2020-11-20 | 广州白云山汉方现代药业有限公司 | Accurate control method for palmitic acid content in olive oil |
CN113163783A (en) * | 2018-11-20 | 2021-07-23 | 花王株式会社 | Oil and fat composition |
CN113528227A (en) * | 2020-04-14 | 2021-10-22 | 丰益(上海)生物技术研发中心有限公司 | Peanut oil preparation method and peanut oil |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110166224A1 (en) | 2008-08-11 | 2011-07-07 | Kishore Ganesh M | Diacylglycerol rich fats, oils and functional foods |
JP5717352B2 (en) * | 2010-03-17 | 2015-05-13 | 花王株式会社 | Method for producing refined fats and oils |
MY164377A (en) * | 2010-10-12 | 2017-12-15 | Sime Darby Malaysia Berhad | Process for production of diacylgylcerol-enriched oil or fat |
US9010339B2 (en) * | 2011-05-27 | 2015-04-21 | R.J. Reynolds Tobacco Company | Method for producing triacetin from tobacco |
CN102805161A (en) * | 2011-05-30 | 2012-12-05 | 上海亿康生物医药科技有限公司 | Long chain molecule vegetable blend oil |
JP5925638B2 (en) | 2011-08-22 | 2016-05-25 | 花王株式会社 | Oil composition |
WO2015111902A1 (en) * | 2014-01-21 | 2015-07-30 | 주식회사 벤스랩 | Fermented vegetable oil having high content of free essential unsaturated fatty acid and method for preparing same |
KR101452320B1 (en) * | 2014-03-11 | 2014-10-22 | 주식회사 벤스랩 | FERMENTED CAMELLIA JAPONICA SEED OIL INHIBITING 5-α REDUCTASE FOR IMPROVEMENT OF BENIGN PROSTATIC HYPERPLASIA AND ALOPECIA |
CN106720821B (en) * | 2016-11-17 | 2020-05-19 | 湖南科技学院 | A cocoa butter substitute prepared by tea oil glycerolysis method and its preparation method |
DK4017270T3 (en) | 2019-08-20 | 2024-05-21 | Bunge Loders Croklaan B V | Fat composition |
KR102605848B1 (en) * | 2021-09-28 | 2023-11-24 | 충북대학교 산학협력단 | Restructured camellia japonica seed oil and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361980B2 (en) * | 1999-12-17 | 2002-03-26 | Kao Corporation | Preparation process of diglyceride |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678580A (en) * | 1986-01-27 | 1987-07-07 | Akzo America Inc. | Hydrolysis of fats |
US5149642A (en) * | 1990-04-20 | 1992-09-22 | The Procter & Gamble Company | Process for preparing 2-acylglycerides or 1,2 or 2,3-diacylglycerides |
US6261812B1 (en) * | 1997-08-18 | 2001-07-17 | Kao Corporation | Process for producing diglycerides |
CA2279402C (en) * | 1998-03-24 | 2009-04-07 | Kao Corporation | Oil or fat composition containing phytosterol |
US6139897A (en) * | 1998-03-24 | 2000-10-31 | Kao Corporation | Oil or fat composition containing phytosterol |
JP3720194B2 (en) * | 1998-07-09 | 2005-11-24 | 花王株式会社 | Method for producing partial glycerides |
IT1304143B1 (en) * | 1998-12-02 | 2001-03-07 | New Holland Italia Spa | FRONT AXLE ASSEMBLY OF A TRACTOR, OR SIMILAR VEHICLE. |
JP4995377B2 (en) * | 2001-04-26 | 2012-08-08 | 花王株式会社 | Oil composition |
IL147942A0 (en) * | 2002-01-31 | 2002-08-14 | Enzymotec Ltd | Method of fractionation of phytosterol esters in oil and products obtained thereby |
-
2005
- 2005-12-28 MY MYPI20056218A patent/MY142033A/en unknown
-
2006
- 2006-05-09 AT AT06252452T patent/ATE443773T1/en active
- 2006-05-09 ES ES06252452T patent/ES2333461T3/en active Active
- 2006-05-09 DE DE602006009367T patent/DE602006009367D1/en active Active
- 2006-05-09 EP EP06252452A patent/EP1803819B1/en not_active Not-in-force
- 2006-05-24 US US11/439,447 patent/US20070148745A1/en not_active Abandoned
- 2006-06-21 JP JP2006170926A patent/JP2007175049A/en active Pending
- 2006-12-28 ES ES06835632T patent/ES2357690T3/en active Active
- 2006-12-28 DE DE602006019912T patent/DE602006019912D1/en active Active
- 2006-12-28 US US12/159,430 patent/US7943335B2/en not_active Expired - Fee Related
- 2006-12-28 JP JP2008548444A patent/JP2009521920A/en active Pending
- 2006-12-28 EP EP06835632A patent/EP1966387B1/en not_active Not-in-force
- 2006-12-28 WO PCT/MY2006/000034 patent/WO2007075079A1/en active Application Filing
- 2006-12-28 AT AT06835632T patent/ATE497012T1/en active
-
2009
- 2009-02-12 HK HK09101345.1A patent/HK1124366A1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361980B2 (en) * | 1999-12-17 | 2002-03-26 | Kao Corporation | Preparation process of diglyceride |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011075802A1 (en) | 2009-12-24 | 2011-06-30 | Companhia Refinadora Da Amazônia | Production of diacylglycerols by lipase - catalyzed hydrolysis of palm oil |
CN107326050A (en) * | 2017-07-13 | 2017-11-07 | 暨南大学 | A kind of purification process of middle chain and middle long-chain mixing diglyceride |
WO2019234057A1 (en) | 2018-06-05 | 2019-12-12 | Dsm Ip Assets B.V. | Process for the production of diglycerides |
CN112513235A (en) * | 2018-06-05 | 2021-03-16 | 帝斯曼知识产权资产管理有限公司 | Process for producing diglycerides |
CN113163783A (en) * | 2018-11-20 | 2021-07-23 | 花王株式会社 | Oil and fat composition |
US12089610B2 (en) | 2018-11-20 | 2024-09-17 | Kao Corporation | Oil and fat composition |
CN111378700A (en) * | 2020-02-24 | 2020-07-07 | 广东聚石化学股份有限公司 | Preparation method of camellia oil fatty acid ester |
CN113528227A (en) * | 2020-04-14 | 2021-10-22 | 丰益(上海)生物技术研发中心有限公司 | Peanut oil preparation method and peanut oil |
CN111961527A (en) * | 2020-09-03 | 2020-11-20 | 广州白云山汉方现代药业有限公司 | Accurate control method for palmitic acid content in olive oil |
Also Published As
Publication number | Publication date |
---|---|
EP1966387A4 (en) | 2009-11-11 |
EP1803819A2 (en) | 2007-07-04 |
JP2009521920A (en) | 2009-06-11 |
DE602006009367D1 (en) | 2009-11-05 |
ATE443773T1 (en) | 2009-10-15 |
WO2007075079A8 (en) | 2008-02-07 |
EP1803819B1 (en) | 2009-09-23 |
JP2007175049A (en) | 2007-07-12 |
DE602006019912D1 (en) | 2011-03-10 |
EP1966387B1 (en) | 2011-01-26 |
MY142033A (en) | 2010-08-16 |
ES2357690T3 (en) | 2011-04-28 |
US7943335B2 (en) | 2011-05-17 |
US20080312342A1 (en) | 2008-12-18 |
EP1966387A1 (en) | 2008-09-10 |
HK1124366A1 (en) | 2009-07-10 |
WO2007075079A1 (en) | 2007-07-05 |
ES2333461T3 (en) | 2010-02-22 |
EP1803819A3 (en) | 2007-07-11 |
ATE497012T1 (en) | 2011-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7943335B2 (en) | Process for the production of diacylglycerol | |
KR100684642B1 (en) | Glyceride oil composition from fish oil and preparation method thereof | |
Ferreira-Dias et al. | The potential use of lipases in the production of fatty acid derivatives for the food and nutraceutical industries | |
Wang et al. | From microalgae oil to produce novel structured triacylglycerols enriched with unsaturated fatty acids | |
KR101943661B1 (en) | Process for production of oil or fat containing highly unsaturated fatty acid using lipase | |
Speranza et al. | Lipase-mediated production of specific lipids with improved biological and physicochemical properties | |
US7220873B2 (en) | Conjugated fatty acid containing monoglycerides and process for producing them | |
US11840714B2 (en) | Enriching DHA in glyceride fractions | |
He et al. | Synthesis of novel medium-long-medium type structured lipids from microalgae oil via two-step enzymatic reactions | |
WO2012118173A1 (en) | Method of producing oil/fat comprising highly-unsaturated fatty acids by means of lipase | |
US20080248187A1 (en) | Mixture containing fatty acid glycerides | |
US20070148746A1 (en) | Process for the enzymatic synthesis of triglycerides | |
Ferreira-Dias et al. | Bioprocess technologies for production of structured lipids as nutraceuticals | |
Kuo et al. | Enzymatic synthesis of structured lipids | |
JP6175198B2 (en) | Method for producing DHA-containing glyceride-containing composition | |
Shimada et al. | Production of functional lipids containing polyunsaturated fatty acids with lipase | |
JP5782130B2 (en) | Process for producing diacylglycerol-enriched oil or fat | |
JP2004168985A (en) | Omega-3 type highly unsaturated fatty acid-containing partial glyceride composition and its production | |
Zhou et al. | Lipase‐catalyzed production of structured lipids via acidolysis of fish oil with caprylic acid | |
US7737289B2 (en) | Process for enriching polyunsaturated fatty acids | |
JP3544247B2 (en) | Pharmaceutical composition for inhibiting platelet aggregation | |
JP7382942B2 (en) | Method for producing glyceride containing docosahexaenoic acid using lipase hydrolysis reaction | |
KR20180121718A (en) | Improved method for preparing monoacylglycerol by using enzymatic alcoholysis | |
Shimada et al. | Application of multistep reactions with lipases to the oil and fat industry | |
Weber et al. | 28Lipid Biotechnology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |